API | rose bengal sodium i-131

rose bengal sodium i-131 (Robengatope) Report issue

Small molecule Imaging Approved ^FDA Priority Review ^FDA

AACT ChEMBL Drugs@FDA PubChem

Active Ingredient History

NOW

Chemistry

SMILES: OC(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C2=C3C=C([131I])C(=O)C([131I])=C3OC4=C2C=C([131I])C(O)=C4[131I]
InChIKey: VDNLFJGJEQUWRB-CJXAGYTBSA-N
Mol. Mass: 989.679
ALogP: Missing data
ChEMBL Molecule:
None

More Chemistry

Pharmacology

Mechanism of Action:
Multi-specific: Missing data
Imaging: 131-iodine
Black Box: Missing data
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: Missing data

Organizations (4)

Research & Development (2)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (2)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (2)

Approved Indications (1)

Liver Function Tests (approved 1971)

Experimental Indications - Clinical Trial Phases 1-4 (1)

Melanoma (Phase 1/Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 2
# of Trial Organizations: 2

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue